secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001193125-25-071399
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace drops SEEG distribution deal to focus on core RNS System; reaffirms 2025 guidance
--------------------------------------------------------------------------------

- Terminated exclusive DIXI Medical SEEG distribution; wind down begins Q4 2025 through Q1 2026.
- CEO cites strategic refocus on RNS System; expects growth from Project CARE, indication expansions, AI software.
- Maintaining 2025 revenue guidance; no change to long-range plan of 20%+ CAGR and cash flow breakeven by end of 2027.
- Gross margin expected to improve: SEEG margin ~50% vs. RNS margin >78%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000119312525071399/0001193125-25-071399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000119312525071399/d949067d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-071399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer